ARAY vs MRNA · rev $401.9M vs rev $145.0M
Accuray Incorporated (ARAY) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Accuray Incorporated (ARAY) is a medical devices company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported ARAY revenue for 2026-06-30 was $401.9M. Net income was -$49.2M. Revenue was down 12.3% from 2025-06-30 to 2026-06-30. ARAY currently screens at market cap $140.1M.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
ARAY currently screens at market cap $140.1M. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the ARAY and MRNA stock pages for the full models.
Not investment advice.